OFFER TO SELL CORONAVAC
The Algerian pharmaceutical company that widely exports human drugs to North, Central and West African countries, Saidal has developed a Corona Vaccine codenamed CoronaVacin partnership with the Sinovac Chinese Laboratory.
Marketing of this vaccine in Algeria was launched after obtaining the Registration Decision on the 30th December 2021 and this was after having gone through the various required test stages for efficiency and safety.
Whereas it was produced primarily to meet the domestic demand, Saidal also intends to export this vaccine to a wider African market, including Uganda, as its production capacity is currently at 60 million doses per annum and can be adjusted upwards to cater for the international demand, especially to the African market in line with the common goal of African Economic Integration.
